The effect of GH replacement therapy on different fat compartments: A whole-body magnetic resonance imaging study

European Journal of Endocrinology

Volumn 164, Issue 1, 2011, Pages 23-29

  Egger, A ^a   Buehler, T ^b   Boesch, C ^b   Diem, P ^a   Stettler, C ^a   Christ, E R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; GROWTH HORMONE;

ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; EXERCISE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INFRARED RADIATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID ANALYSIS; MALE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WHOLE BODY MRI; ADULT; ANTHROPOMETRIC PARAMETERS; BODY FAT DISTRIBUTION; DRUG EFFICACY; FAT MASS; OUTCOME ASSESSMENT; SEDENTARY LIFESTYLE; TREADMILL EXERCISE; WORKLOAD;

ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INTRA-ABDOMINAL FAT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEDENTARY LIFESTYLE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

EID: 78751542510     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0702     Document Type: Article

References (31)

1. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T & Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395. (doi:10.1210/jc.83.2.382)
2. Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C & Colao A. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. Journal of Clinical Endocrinology and Metabolism 2000 85 3720-3725. (doi:10.1210/jc.85.10.3720)
3. Bengtsson BA. Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism. Growth Hormone & IGF Research 1998 8 (Supplement A) 77-80. (doi:10.1016/S1096-6374(98)80014-2)
4. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L & Isaksson OG. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 1993 76 309-317. (doi:10.1210/jc.76.2.309) (Pubitemid 23073047)
5. Fowelin J, Attvall S, Lager I & Bengtsson BA. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 1993 42 1443-1447. (doi:10.1016/0026-0495(93)90197-V) (Pubitemid 23335878)
6. Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, Sjostrom L & Bengtsson BA. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism 1997 82 727-734. (doi:10.1210/jc.82.3.727)
7. Koranyi J, Bosaeus I, Alpsten M, Bengtsson BA & Johannsson G. Body composition during GH replacement in adults - methodological variations with respect to gender. European Journal of Endocrinology 2006 154 545-553. (doi:10.1530/eje.1.02118)
8. Christ ER, Cummings MH,Westwood NB, Sawyer BM, Pearson TC, Sonksen PH & Russell-Jones DL. The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1997 82 2985-2990. (doi:10.1210/jc.82.9.2985)
9. Snel YE, Doerga ME, Brummer RM, Zelissen PM & Koppeschaar HP. Magnetic resonance imaging-assessed adipose tissue and serum lipid and insulin concentrations in growth hormone-deficient adults. Effect of growth hormone replacement. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 1543-1548.
10. Attanasio AF, Howell S, Bates PC, Frewer P, Chipman J, Blum WF & Shalet SM. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. Journal of Clinical Endocrinology and Metabolism 2002 87 3368-3372. (doi:10.1210/jc.87.7.3368) (Pubitemid 34822873)
11. Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, Lebl J, Chipman JJ & Shalet SM. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 2004 89 4857-4862. (doi:10.1210/jc.2004-0551)
12. Weaver JU, Monson JP, Noonan K, John WG, Edwards A, Evans KA & Cunningham J. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 1995 80 153-159. (doi:10.1210/jc.80.1.153)
13. Moller J, Frandsen E, Fisker S, Jorgensen JO & Christiansen JS. Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clinical Endocrinology 1996 44 533-539. (doi:10.1046/j.1365-2265.1996. 728550.x)
14. Salomon F, Cuneo RC, Hesp R & Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 1989 321 1797-1803. (doi:10.1056/NEJM198912283212605)
15. Haymond MW, Sunehag AL & Ellis KJ. Body composition as a clinical endpoint in the treatment of growth hormone deficiency. Hormone Research 1999 51 (Supplement 3) 132-140. (doi:10.1159/000053176)
16. Ludescher B, Machann J, Eschweiler GW, Vanhofen S, Maenz C, Thamer C, Claussen CD & Schick F. Correlation of fat distribution in whole body MRI with generally used anthropometric data. Investigative Radiology 2009 44 712-719. (doi:10.1097/RLI.0b013e3181afbb1e)
17. Thomas EL, Saeed N, Hajnal JV, Brynes A, Goldstone AP, Frost G & Bell JD. Magnetic resonance imaging of total body fat. Journal of Applied Physiology 1998 85 1778-1785. (Pubitemid 28516412)
18. Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, Claussen CD, Stumvoll M, Fritsche A & Schick F. Standardized assessment of whole body adipose tissue topography by MRI. Journal of Magnetic Resonance Imaging 2005 21 455-462. (doi:10.1002/jmri.20292)
19. Sonksen PH & Christiansen JS. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. Growth Hormone Research Society. Growth Hormone & IGF Research 1998 8 (Supplement B) 89-92. (doi:10.1016/S1096-6374(98)80028-2)
20. Buehler TRN, Machann J, Schwenzer N & Boesch C. Determination of body compartments at 1.5 and 3 Tesla combining three volume estimation methods. Proceedings of the International Society for Magnetic Resonance in Medicine 2010 18 2915.
21. Buehler TCD & Boesch C. Determination of whole body fat and visceral adipose tissue, combining three volume estimation methods. Proceedings of the International Society for Magnetic Resonance in Medicine 2009 17 2872.
22. Boesch C, Machann J, Vermathen P & Schick F. Role of proton MR for the study of muscle lipid metabolism. NMR in Biomedicine 2006 19 968-988. (doi:10.1002/nbm.1096)
23. Visser M, Gallagher D, Deurenberg P, Wang J, Pierson RN Jr & Heymsfield SB. Density of fat-free body mass: relationship with race, age, and level of body fatness. American Journal of Physiology 1997 272 E781-E787.
24. Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT & Ross RJ. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clinical Endocrinology 2004 61 367-375. (doi:10.1111/j.1365-2265.2004.02106.x)
25. Snel YE, Brummer RJ, Doerga ME, Zelissen PM, Bakker CJ, HendriksMJ & Koppeschaar HP. Adipose tissue assessed bymagnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects. American Journal of Clinical Nutrition 1995 61 1290-1294.
26. Danilowicz K, Bruno OD, Manavela M, Gomez RM & Barkan A. Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary 2008 11 279-285. (doi:10.1007/s11102- 008-0126-2)
27. Johannsson G & Bengtsson BA. Growth hormone and the metabolic syndrome. Journal of Endocrinological Investigation 1999 22 41-46.
28. Jorgensen JO, Krag M, Jessen N, Norrelund H, Vestergaard ET, Moller N & Christiansen JS. Growth hormone and glucose homeostasis. Hormone Research 2004 62 (Supplement 3) 51-55. (doi:10.1159/000080499)
29. Fowelin J, Attvall S, von Schenck H, Bengtsson BA, Smith U & Lager I. Effect of prolonged hyperglycemia on growth hormone levels and insulin sensitivity in insulin-dependent diabetes mellitus. Metabolism 1993 42 387-394. (doi:10.1016/0026-0495(93)90092-3) (Pubitemid 23073360)
30. Fisker S, Hansen B, Fuglsang J, Kristensen K, Ovesen P, Orskov H & Jorgensen JO. Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein. European Journal of Endocrinology 2004 150 773-777. (doi:10.1530/eje.0.1500773)
31. Agha A & Monson JP. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clinical Endocrinology 2007 66 459-465. (doi:10.1111/j.1365-2265.2007.02763.x)